We are so excited to announce that we have hired Shana Trexler as a Senior Account Executive to advance sales of RE Assist. A Fierce Healthcare Innovation winner in 2024, RE Assist is an innovative tool that supports people living with disease find financial support for their treatment costs.
read full article ›As expected, the U.S. Department of Health and Human Services announced the second round of drugs that will be subject to “negotiation” under the Inflation Reduction Act. It’s the last major healthcare move from the Biden Administration and a chance to keep the momentum going on its signature leglislation. Here is what we know – and what we don’t.
read full article ›Direct to consumer pharma models are a hot topic here at Real Endpoints. Roger Longman has thoughts. Let us know yours in the comments.
read full article ›Roger Longman isn't the only RE team member thinking deep thoughts about health care while in a beautiful place. Ellen Licking talks site of care optimization in this post. Add to the discussion in the comments.
read full article ›Real Endpoints is coast to coast this week with our Chairman, Roger Longman leading a panel in California at a biotech meeting and our CEO, Jeff Berkowitz presenting at the IFPW 2024 Annual Meeting in Key Biscayne, Florida!
read full article ›And just like that ...one day after it released its excoriating report, the FTC apparently plans to file a lawsuit against the 3 big PBMs for their rebate practices linked to insulin and other medicines according to The Wall Street Journal.
read full article ›We are so excited to announce that we’ve been shortlisted for the Fierce Innovation Awards: Healthcare Edition 2024.
read full article ›This recent BioCentury Inc. article highlights one of the potential consequences of the hashtag#InflationReductionAct: tighter formularies for Part D drugs as plans look for mechanisms to manage their increased liability under the redesigned Part D benefit beginning in 2025.
read full article ›The snark is strong with PhRMA. In a new ad campaign featuring smarmy health plan and PBM “suits,” the industry trade group points a very big finger at healthcare middlemen. But you don’t have to be a communications Jedi Master to see how this kind of messaging could move quickly from being seen as tongue-in-cheek to insert foot-in-mouth.
read full article ›